CRMD
CorMedix Inc.
$7.92
+0.00%
2026-05-08
About CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Key Fundamentals
P/E Ratio
3.92
Forward P/E
11.10
EPS (TTM)
$2.04
ROE
66.6%
Revenue Growth (YoY)
312.1%
Profit Margin
52.3%
Debt/Equity
36.74
Price/Book
1.56
Beta
1.46
Market Cap
$626.8M
Avg Volume (10D)
995K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$8.15
60D Low
$6.13
Avg Volume
1.2M
Latest Close
$7.92
Get breakout alerts for CRMD
Sign up for Breakout Scanner to receive daily notifications when CRMD triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
CorMedix Inc. (CRMD) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CRMD daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CRMD operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.